The neo gene encodes neomycin phosphotransferase, an enzyme that chemically modifies neomycin by phosphorylation. This modification inactivates the antibiotic, preventing it from exerting its normal inhibitory effect on bacterial protein synthesis. As a result, cells carrying the functional resistance gene can continue growing when neomycin is present, whereas cells lacking it are inhibited.
Neomycin creates a selective growth condition: susceptible cells are inhibited because the antibiotic disrupts bacterial protein synthesis, while resistant cells neutralize the compound through neomycin phosphotransferase activity. This difference converts resistance into an observable biological outcome, allowing researchers to distinguish cells with the resistance trait from cells that do not possess effective protection.
The antibiotic normally interferes with bacterial protein synthesis, making exposure inhibitory for susceptible cells. Neomycin resistance changes that outcome through enzymatic inactivation rather than by removing the antibiotic from the system. This contrast helps illustrate how antibiotic activity and resistance mechanisms can act in opposition, providing a model for examining both drug action and cellular protection.
In molecular cloning and transfection, the resistance trait helps identify cells associated with introduced genetic material. Researchers apply neomycin-based selection so that cells able to express the neo-encoded protective activity can grow, while susceptible cells are inhibited. This makes the marker useful for enriching genetically modified cell populations and supporting the establishment of selected cell lines.
The trait serves as a selection tool during the generation of genetically modified cell lines or organisms. After genetic modification, resistance-associated growth provides a way to distinguish selected biological material from material that remains susceptible. Its value is therefore procedural as well as genetic: it links a selectable survival outcome to experiments involving introduced or altered genetic information.
Neomycin resistance supports research at several biological levels. It can be used to examine how aminoglycoside antibiotics act, how cells or microorganisms acquire protection, and how resistance genes may spread. In laboratory systems, it also connects molecular genetics with organismal modification, making the trait relevant to studies of antibiotic resistance mechanisms and genetically altered cells or organisms.